Form 4: Cirrus Logic Executive Trades 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Jeffrey W. Baumgartner, EVP of R&D at Cirrus Logic, executed a Rule 10b5-1 plan transaction involving the acquisition and sale of common stock.
Summary
- Jeffrey W. Baumgartner, Executive Vice President of Research & Development at Cirrus Logic, Inc., engaged in a transaction involving the company's common stock.
- The transaction was executed under a Rule 10b5-1 trading plan adopted by Mr. Baumgartner on February 27, 2026.
- On July 1, 2026, 1,458 shares of common stock were acquired at a price of $68.56 per share.
- On the same date, 1,458 shares of common stock were sold at a price of $145.97 per share.
- Following these transactions, Mr. Baumgartner beneficially owns 16,405 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While the transaction shows a profitable spread, it is a routine execution of a pre-planned trading strategy by an executive and does not inherently signal new positive or negative developments for the company.
Positives
- The transaction was conducted under a pre-established Rule 10b5-1 plan, indicating adherence to a structured trading strategy designed to avoid insider trading concerns.
- The acquisition price of $68.56 per share is significantly lower than the sale price of $145.97 per share, suggesting a profitable execution of the plan for the reporting person.
Negatives
- A significant number of shares (1,458) were sold, which could be interpreted by some investors as a lack of confidence in near-term stock appreciation, despite being part of a plan.
Risks
- The sale of shares, even under a 10b5-1 plan, could lead to negative market perception if not adequately contextualized.
- The price difference between acquisition and sale might reflect market volatility or specific timing within the plan, which could be a risk if future plan executions are less favorable.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. It is a report of past transactions.
Industry Context
StockSavvy.ai notes that the use of Rule 10b5-1 plans by executives is a common practice in the semiconductor industry to manage personal stock holdings while adhering to insider trading regulations. This filing indicates a routine execution of such a plan.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Plan Execution | Transaction executed pursuant to a Rule 10b5-1 trading plan. | 07/01/2026 | Demonstrates adherence to established corporate governance policies for executive stock transactions, mitigating insider trading risks. |
Stakeholder Impact
- Shareholders: The sale of shares by an executive, even under a plan, may be scrutinized by investors. However, the structured nature of the 10b5-1 plan aims to prevent undue influence on stock price or market perception.
- Employees: As a routine executive transaction, it is unlikely to have a direct impact on employees.
- Management: Reinforces the company's commitment to transparent and compliant executive trading practices.
Key Dates
| Date | Description |
|---|---|
| 02/27/2026 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 07/01/2026 | Date of transaction (acquisition and sale of common stock). |
| 07/02/2026 | Date the Form 4 was signed by the attorney-in-fact. |
| 11/06/2023 | Date the incentive stock option was fully vested and exercisable. |
Keywords
Form 4, Insider Trading, Rule 10b5-1, Cirrus Logic, CRUS, Stock Transaction, Beneficial Ownership, Executive Trade, EVP R&D
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.